Search Results - Patrick Schnell

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer:... by Johannes Ettl, Seock-Ah Im, Jungsil Ro, Norikazu Masuda, Marco Colleoni, Patrick Schnell, Eustratios Bananis, Dongrui R. Lu, Massimo Cristofanilli, Hope S. Rugo, Richard S. Finn

    Published in Breast Cancer Research (2020-03-01)
    Get full text
    Article


  2. 2

    Biomechanical effect of neurologic dance training (NDT) for breast cancer survivors with chemotherapy-induced neuropathy: study protocol for a randomized controlled trial and preli... by Kristen Lantis, Patrick Schnell, Courtney R. Bland, Jacqueline Wilder, Karen Hock, Craig Vargo, Nelson A. Glover, Madeleine E. Hackney, Maryam B. Lustberg, Lise Worthen-Chaudhari

    Published in Trials (2023-09-01)
    Get full text
    Article


  3. 3

    Clinical dose rationale of tislelizumab in patients with solid or hematological advanced tumors by Tian Yu, Xiangyu Liu, Chi‐Yuan Wu, Zhiyu Tang, Hongwei Wang, Patrick Schnell, Ya Wan, Kun Wang, Lucy Liu, Yuying Gao, Srikumar Sahasranaman, Nageshwar Budha

    Published in Clinical and Translational Science (2024-03-01)
    Get full text
    Article


  4. 4

    Efficacy and safety of palbociclib in patients with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer with preexisting conditions:... by Karen Gelmon, Janice M. Walshe, Reshma Mahtani, Anil A. Joy, Meghan Karuturi, Patrick Neven, Dongrui Ray Lu, Sindy Kim, Patrick Schnell, Eustratios Bananis, Lee Schwartzberg

    Published in Breast (2021-10-01)
    Get full text
    Article


  5. 5

    Alternative Dosing Regimens of Tislelizumab Using a Pharmacometrics Model‐Based Approach by Ahsan Rizwan, Hugh Giovinazzo, Tian Yu, Yuying Gao, Kun Wang, Fengyan Xu, Ya Wan, Jun Wang, Srikumar Sahasranaman, Marcia Campbell, Patrick Schnell, Ramil Abdrashitov, William D. Hanley, Nageshwar Budha

    Published in Clinical and Translational Science (2025-05-01)
    Get full text
    Article


  6. 6

    Clinical Pharmacology Overview of Tislelizumab in Patients With Advanced Tumors With a Focus on Racial Impact by Tian Yu, Chi‐Yuan Wu, Srikumar Sahasranaman, Xianbin Tian, Ying Fei Li, Zhiyu Tang, Yanfei Yang, Ya Wan, Quting Zhang, Patrick Schnell, Ariadna Mendoza‐Naranjo, Ramil Abdrashitov, William D. Hanley, Nageshwar Budha

    Published in Clinical and Translational Science (2025-05-01)
    Get full text
    Article


Search Tools: